COMPARISON OF PHARMACOKINETIC PARAMETERS OF CYTOCHROME P450 PROBE SUBSTRATES IN HUMANS, MICE, RATS, DOGS, MONKEYS, AND MICROMINIPIGS

被引:0
|
作者
Sakai, Chizuka [1 ]
Iwano, Shunsuke [1 ]
Yamazaki, Yuri [1 ]
Ando, Akihiro [1 ]
Yamazaki, Hiroshi [2 ]
Miyamoto, Yohei [1 ]
机构
[1] Toray Industries Ltd, Pharmaceut Res Labs, Toxicol & Pharmacokinet Labs, Kamakura, Kanagawa, Japan
[2] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Machida, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P85
引用
收藏
页码:79 / 79
页数:1
相关论文
共 50 条
  • [1] Comparison of Cytochrome P450 3A Enzymes in Cynomolgus Monkeys and Humans
    Iwasaki, Kazuhide
    Murayama, Norie
    Koizumi, Ryo
    Uno, Yasuhiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (04) : 388 - 391
  • [2] Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs
    Nishimuta, Haruka
    Nakagawa, Tetsuya
    Nomura, Naruaki
    Yabuki, Masashi
    XENOBIOTICA, 2013, 43 (11) : 948 - 955
  • [3] Comparison of P450 2D and 3A-dependent drug oxidation activities in cynomolgus monkeys, microminipigs, and humans
    Yamazaki, Hiroshi
    Emoto, Chie
    Koizumi, Ryo
    Shimizu, Makiko
    Murayama, Norie
    Iwasaki, Kazuhide
    Utoh, Masahiro
    Uno, Yasuhiro
    DRUG METABOLISM REVIEWS, 2011, 43 : 59 - 60
  • [4] Predicting kinetic parameters for substrates of human cytochrome P450
    Zhang, Jinhua
    Fraczkiewicz, Robert
    Bolger, Michael B.
    Waldman, Marvin
    Woltosz, Walter S.
    Enslein, Kurt
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [5] Reboxetine and cytochrome P450 -: comparison with paroxetine treatment in humans
    Kuhn, U. D.
    Kirsch, M.
    Merkel, U.
    Eberhardt, A. -M.
    Wenda, B.
    Maurer, I.
    Haertter, S.
    Hiemke, C.
    Volz, H. -P.
    Balogh, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (01) : 36 - 46
  • [6] Comparison of P450 Enzymes Between Cynomolgus Monkeys and Humans: P450 Identities, Protein Contents, Kinetic Parameters, and Potential for Inhibitory Profiles
    Emoto, Chie
    Yoda, Noriaki
    Uno, Yasuhiro
    Iwasaki, Kazuhide
    Umehara, Ken
    Kashiyama, Eiji
    Yamazaki, Hiroshi
    CURRENT DRUG METABOLISM, 2013, 14 (02) : 239 - 252
  • [7] Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans
    Chow, T
    Imaoka, S
    Hiroi, T
    Funae, Y
    RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY, 1996, 93 (03) : 363 - 374
  • [8] Probe substrates for human cytochrome p450 isoforms: Evaluation of substrate selectivity
    Guo, Yu
    Wang, Hui
    DRUG METABOLISM REVIEWS, 2006, 38 : 42 - 43
  • [9] Pharmacokinetic drug interactions of asciminib with the sensitive cytochrome P450 probe substrates midazolam, warfarin, and repaglinide in healthy participants
    Hoch, Matthias
    Sengupta, Tirtha
    Hourcade-Potelleret, Florence
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (06): : 1406 - 1416
  • [10] Comparison of Drosophila cytochrome P450 metabolism of natural and model substrates
    Frank, MR
    Danielson, PB
    Fogleman, JC
    JOURNAL OF INSECT PHYSIOLOGY, 1997, 43 (10) : 953 - 957